Description

Metformin HCI Sustained Release & Glimepiride Tablets IP

Composition:

Each uncoated bilayered tablet contains :

Metformin Hydrochloride IF     1000 mg

(as Sustained Release)

Glimepiride IP          4 mg

Colours : Tartrazine Yellow & Brilliant Blue

INDICATION & USE

• Reduced risk of Hypoglycemia

• Controlling high blood sugar